• 70% Dextrose injection, BBraun
  2000 mL bag, 4 count (NDC 00264-7387-50)
  
  70% Dextrose injection, Baxter
  2000 mL bag, 6 count (NDC 00338-0719-06)

• • Baxter has 70% dextrose 2,000 mL bags on shortage due to manufacturing delays.¹
  • BBraun discontinued 70% dextrose in 1,000 mL glass bottles in 2016. The 70% dextrose 2,000 mL bags are on allocation due to increased demand.²
  • Pfizer had 70% dextrose 500 mL in 1000 mL partial fill bags on back order due to manufacturing delays.⁴

• There is insufficient supply for usual ordering

Estimated Resupply Dates

• • Baxter has 70% dextrose 2,000 mL bags on intermittent back order with regular releases.¹
  • BBraun has 70% dextrose 2,000 mL bags available to current customers.²
  • Pfizer has 70% dextrose 2,000 mL bags on back order and the company estimates a release date in early-July 2017. The 500 mL in 1000 mL partial-fill bags are on back order and the company estimates a release date in early-September 2017.⁴

Implications for Patient Care

• Solutions of 70% dextrose are used to compound a variety items including specialized solutions for neonatal or pediatric patients and total parenteral nutrition (TPN).³

Safety

• Clinicians must use care if using another strength of dextrose injection for compounding (such as 50% dextrose injection). Ensure compounding software is updated prior to using a different strength.

Alternative Agents & Management

• • Clinicians should reserve remaining supplies of 70% dextrose for their most critical patients.
  • Consider using premixed total parenteral nutrition solutions if appropriate.

References

• 1. Baxter (personal communication). March 8, 2017.
  2. BBraun (personal communication). March 7 and July 7, 2017.
  3. BBraun. 70% Dextrose Injection, USP [product information]. Bethlehem, PA: BBraun; 2015.
  4. Pfizer (website). March 9, April 18, and July 7, 2017.